Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia.
currently an undergraduate at the University of Pennsylvania, Philadelphia.
JAMA Neurol. 2014 Aug;71(8):1003-8. doi: 10.1001/jamaneurol.2014.999.
The anti-Tr immune response is associated with paraneoplastic cerebellar degeneration and Hodgkin lymphoma (HL). One case series has reported that the Delta/notch-like epidermal growth factor-related receptor (DNER) is the actual target for anti-Tr antibodies, but this result has not been replicated.
To describe a patient with anti-Tr and confirm that DNER is the autoantigen for a series of patients with anti-Tr.
DESIGN, SETTING, AND PARTICIPANTS: Observational study and analysis of biological samples for antibodies to DNER at the hospital of the University of Pennsylvania. We examined a cerebrospinal fluid sample from 1 patient with anti-Tr and serum and/or cerebrospinal fluid samples from 5 other patients with anti-Tr.
Transfection of HEK293T and Hela cells to express DNER coupled to an enhanced green fluorescent protein tag using a plasmid previously used to detect human DNER antibodies.
A man in his 30s with paraneoplastic cerebellar degeneration and anti-Tr underwent treatment with corticosteroids and intravenous immunoglobulin, resulting in clinical improvement before chemotherapy. Despite close oncologic follow-up, a biopsy, positron emission tomography, and computed tomography, he was not diagnosed as having HL until 6 months after symptom onset. The cerebrospinal fluid sample from this patient reacted with cells transfected to express DNER, as did cerebrospinal fluid and/or serum samples from 5 other patients with paraneoplastic cerebellar degeneration, HL, and anti-Tr. Only 4 of the 5 serum samples reacted to permeabilized cells enough to be distinguished from background, but all 5 serum samples convincingly labeled live cells, which had considerably less background. All 6 control serum samples and 1 serum sample from a patient previously diagnosed as having anti-Tr (but without HL or cerebellitis) did not recognize DNER.
This case demonstrates the importance of testing for the anti-Tr immune response in patients with cerebellar degeneration. The strong association of anti-Tr with HL requires careful surveillance for this tumor. We also confirm that DNER is the target antigen of the anti-Tr immune response. Screening for DNER antibodies against living transfected cells may offer an improved signal-to-noise characteristic compared with immunostaining of fixed, permeabilized cells.
抗 Tr 免疫反应与副肿瘤性小脑变性和霍奇金淋巴瘤(HL)有关。有一项病例系列报告称,Delta/notch 样表皮生长因子相关受体(DNER)是抗 Tr 抗体的实际靶标,但这一结果尚未得到复制。
描述一名抗 Tr 患者,并确认 DNER 是一系列抗 Tr 患者的自身抗原。
设计、地点和参与者:在宾夕法尼亚大学医院进行的观察性研究和针对 DNER 抗体的生物样本分析。我们检查了 1 名抗 Tr 患者的脑脊液样本,以及另外 5 名抗 Tr 患者的血清和/或脑脊液样本。
使用先前用于检测人 DNER 抗体的质粒,转染 HEK293T 和 Hela 细胞以表达与增强型绿色荧光蛋白标签偶联的 DNER。
一名 30 多岁的男性患有副肿瘤性小脑变性和抗 Tr,接受了皮质类固醇和静脉注射免疫球蛋白治疗,在化疗前临床症状有所改善。尽管进行了密切的肿瘤随访、活检、正电子发射断层扫描和计算机断层扫描,但直到症状出现后 6 个月才被诊断为 HL。该患者的脑脊液样本与转染表达 DNER 的细胞反应,另外 5 名患有副肿瘤性小脑变性、HL 和抗 Tr 的患者的脑脊液和/或血清样本也与转染表达 DNER 的细胞反应。只有 5 份血清样本中的 4 份对透化细胞的反应足以与背景区分开来,但 5 份血清样本都令人信服地标记了活细胞,而活细胞的背景要少得多。所有 6 份对照血清样本和 1 份以前诊断为抗 Tr(但无 HL 或小脑炎)的患者的血清样本均未识别 DNER。
本病例表明,在患有小脑变性的患者中检测抗 Tr 免疫反应非常重要。抗 Tr 与 HL 的强烈关联需要对这种肿瘤进行仔细监测。我们还确认 DNER 是抗 Tr 免疫反应的靶抗原。与固定、透化细胞的免疫染色相比,针对活转染细胞的 DNER 抗体筛查可能提供更好的信噪比特征。